Compare TCOM & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCOM | STE |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | Singapore | United States |
| Employees | N/A | 3700 |
| Industry | Hotels/Resorts | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 22.6B |
| IPO Year | 2003 | 2018 |
| Metric | TCOM | STE |
|---|---|---|
| Price | $38.50 | $231.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 29 | 8 |
| Target Price | $58.71 | ★ $260.71 |
| AVG Volume (30 Days) | ★ 2.3M | 639.8K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | 0.78% | ★ 1.21% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | N/A | ★ $5,935,900,000.00 |
| Revenue This Year | $6.70 | $7.47 |
| Revenue Next Year | $9.05 | $6.73 |
| P/E Ratio | ★ $9.06 | $28.90 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $37.58 | $195.14 |
| 52 Week High | $79.00 | $269.44 |
| Indicator | TCOM | STE |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 65.59 |
| Support Level | $37.81 | $227.89 |
| Resistance Level | $41.49 | $239.13 |
| Average True Range (ATR) | 0.64 | 5.05 |
| MACD | 0.06 | 1.34 |
| Stochastic Oscillator | 11.48 | 88.38 |
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel, as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of the revenue comes from package tours and corporate travel. Before the pandemic in 2019, the firm generated 25% of revenue from international travel, which is important to its margin expansion.Most of its sales come from its domestic platform, but the company is expanding its overseas business. It competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.